Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kaiwen, Chi"'
Autor:
Kaiwen Chi, Wei Sun, Xin Yang, Jianghua Wu, Haiyue Wang, Xinying Liu, Luning Mao, Lixin Zhou, Xiaozheng Huang, Dongmei Lin
Publikováno v:
Thoracic Cancer, Vol 13, Iss 7, Pp 1050-1058 (2022)
Abstract Background Tumor immune cell infiltration is important in the prognosis of patients with lung adenocarcinoma. The aim of this study was to develop a prognostic classification based on the tumor immunoscore. Methods Patients with KRAS‐mutan
Externí odkaz:
https://doaj.org/article/5feb13a5ac4341928138937b40be4dbc
Autor:
Lin, Luning Mao, Jianghua Wu, Zhongjie Zhang, Lijun Mao, Yuejin Dong, Zufeng He, Haiyue Wang, Kaiwen Chi, Yumeng Jiang, Dongmei
Publikováno v:
Cancers; Volume 15; Issue 12; Pages: 3171
(1) Background: Chromatin structure typing has been used for prognostic risk stratification among cancer survivors. This study aimed to ascertain the prognostic values of ploidy, nucleotyping, and tumor–stroma ratio (TSR) in predicting disease prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::fc64fbf5272e4d0906a95874a1a87f67
Autor:
Wei Sun, Shuai Zhao, Luning Mao, Kaiwen Chi, Tingting Ding, Haiyue Wang, Lixin Zhou, Jianghua Wu, Dongmei Lin, Xin Yang, Xiaozheng Huang, Xinying Liu, Bin Meng
Publikováno v:
Modern Pathology. 35:218-227
Metastatic tumors (MTs) may show different characteristics of the immune microenvironment from primary tumors (PTs) in non-small cell lung cancer (NSCLC). The heterogeneity of immune markers in metastatic NSCLC and its associated factors has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3607269248d1dfaf3a79d224c9d909d
https://doi.org/10.1038/s41379-021-00903-w
https://doi.org/10.1038/s41379-021-00903-w
Autor:
Yifei Zhu, Kaiwen Chi, Cuiling Liu, Zhaoyue Meng, Lai-Kwok Leung, Xin Hu, Xiaoqiang Yao, Franky L. Chan, Mingxu Xie
Publikováno v:
Oncogene. 38:5778-5791
Drug resistance is one of the major obstacles to breast cancer therapy. However, the mechanisms of how cancer cells develop chemoresistance are still not fully understood. In the present study, we found that expression of TM9SF4 proteins was much hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23dc5ef0be80c341607bd66f18376671
https://doi.org/10.1038/s41388-019-0846-y
https://doi.org/10.1038/s41388-019-0846-y
Autor:
Jianghua, Wu, Changling, Liu, Xiaoqing, Liu, Wei, Sun, Linfeng, Li, Nannan, Gao, Yajun, Zhang, Xin, Yang, Junjie, Zhang, Haiyue, Wang, Xinying, Liu, Xiaozheng, Huang, Yanhui, Zhang, Runfen, Cheng, Kaiwen, Chi, Luning, Mao, Lixin, Zhou, Dongmei, Lin, Shaoping, Ling
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(3)
Standardized programmed death-ligand 1 (PD-L1) assessment in non-small cell lung cancer (NSCLC) is challenging, owing to inter-observer variability among pathologists and the use of different antibodies. There is a strong demand for the development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27958e1a4f0d6db977ff4c0737998696
https://pubmed.ncbi.nlm.nih.gov/34518630
https://pubmed.ncbi.nlm.nih.gov/34518630
Autor:
Jianghua, Wu, Wei, Sun, Xin, Yang, Haiyue, Wang, Xinying, Liu, Kaiwen, Chi, Lixin, Zhou, Xiaozheng, Huang, Luning, Mao, Shuai, Zhao, Tingting, Ding, Bin, Meng, Dongmei, Lin
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(2)
Metastatic tumors (MTs) may show different characteristics of the immune microenvironment from primary tumors (PTs) in non-small cell lung cancer (NSCLC). The heterogeneity of immune markers in metastatic NSCLC and its associated factors has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce67561433d226040ba12a67704f9a08
https://pubmed.ncbi.nlm.nih.gov/34493824
https://pubmed.ncbi.nlm.nih.gov/34493824
Autor:
Yue Yang, Xin Yang, Wei Sun, Kaiwen Chi, Yuan Feng, Xinying Liu, Dongmei Lin, Jianghua Wu, Luning Mao, Haiyue Wang, Mailin Chen
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 34(11)
For neoadjuvant therapy in patients with non-small cell lung cancer, the major pathologic response of primary tumors may be an assessable and reliable surrogate measure of survival. Few studies have examined the pathologic evaluation of metastatic ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::670c1cd4f32ea9fc4613d8a3c09858e9
https://pubmed.ncbi.nlm.nih.gov/34253867
https://pubmed.ncbi.nlm.nih.gov/34253867
Autor:
Luning Mao, Kaiwen Chi, Jianghua Wu, Xiaozheng Huang, Dongmei Lin, Xinying Liu, Wei Sun, Xin Yang, Haiyue Wang
Publikováno v:
Journal of clinical pathology. 75(7)
AimsThis study aimed to validate the application of combined multiplex immunofluorescence (mIF) and digital image analysis (DIA) in formalin-fixed and paraffin-embedded tissues for the quantitative assessment of programmed death-ligand 1(PD-L1) and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::871c9b89b1a6307655d4a5b2676f9efa
https://pubmed.ncbi.nlm.nih.gov/33782193
https://pubmed.ncbi.nlm.nih.gov/33782193
Autor:
Jianghua Wu, Luning Mao, Wei Sun, Xin Yang, Haiyue Wang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Dongmei Lin
Publikováno v:
Journal of Clinical Pathology; Jul2022, Vol. 75 Issue 7, p452-458, 7p
Autor:
Yifei, Zhu, Mingxu, Xie, Zhaoyue, Meng, Lai-Kwok, Leung, Franky Leung, Chan, Xin, Hu, Kaiwen, Chi, Cuiling, Liu, Xiaoqiang, Yao
Publikováno v:
Oncogene. 38(29)
Drug resistance is one of the major obstacles to breast cancer therapy. However, the mechanisms of how cancer cells develop chemoresistance are still not fully understood. In the present study, we found that expression of TM9SF4 proteins was much hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64f6568ff6acd36394fa157dda2fd88e
https://pubmed.ncbi.nlm.nih.gov/31249383
https://pubmed.ncbi.nlm.nih.gov/31249383